Q3 2020 CLARIVATE PLC Earnings Call
Good morning, and welcome to the clarity analytics third quarter 2020 earnings conference call.
Participants will be in a listen only mode should you need assistance. Please take my conference specialist by pressing the star keep all the base year after.
After todays presentation, there will be an opportunity to ask questions. Please.
Please note. This event is being recorded I would now like turn the conference over to Mark Donohue, Vice President Investor Relations. Please go ahead.
Thank you Lisa and good morning, everyone. Thank you for joining us for the clarity <unk> third quarter 2020 earnings conference call.
Today are Gerry dead Executive Chairman, and Chief Executive Officer, Richard Hayne, Chief Financial Officer.
Med President Science group, Jeff Boyd President of IP group.
All will be available to take your questions at the inclusion of prepared remarks.
As a reminder, this conference call is being recorded webcast copyrighted property of clarity.
Rebroadcast of this information in whole weren't part.
<unk> prior written consent of clarity is prohibited.
Good morning, Clara issued a press release announcing our financial results for the period ended September 32020.
Really as well as an accompanying supplemental presentation is available.
In the Investor Relations section of the company's website clarity dot com under events and presentation.
During our call we may make certain forward looking statements within the meaning of the securities law.
Such forward looking statements.
I've known or unknown risks uncertainties and other factors that may cause the actual results performance or achievements of the business or development declared its industry to differ materially from the anticipated results performance achievements or developments expressed or implied by such forward looking statements.
Information about the factors that could cause actual results to differ materially from anticipated results are performing.
Can be found in <unk> filings with the US you see it on the company's website.
Our discussion will include non-GAAP measures are adjusted numbers, including adjusted revenue adjusted EBITDA.
Clarity bleed non-GAAP results are useful in order to enhance the understanding of our ongoing operating performance.
They're a supplement to and you're not be considered isolation from or is it stops you forget fragile matters.
Reconciliation of these measures to GAAP measures are dalbar andreessen supplemental presentation.
Posted on our website.
After prepared remarks, we'll open the call to your question so without the pleasure to turn the call over Jerry.
Thank you Mark and thanks to all of you for joining US. This morning. It was another very busy quarter for our company as we announced a transformative acquisition and delivered a very solid quarter of go.
What we're accomplishing this year in the face of it and then they can simply amazing to me I couldn't be prouder of our global team for driving improvement in our financial results executing on business development M&A opportunities delivering enhanced product offerings driving improved colleague engagement customer delights.
Bars, and rolling around social causes to make the world a better place first let's talk about our financial performance adjusted revenue for the third quarter was $286 million, an increase of 16% at constant currency as we benefited from recent acquisitions, including DRG and subscription.
<unk>, excluding divested business businesses adjusted revenue increased 22% organic subscription revenue grew 4% driven by new business and annual price increase organic transactional Robin do continue to feel the effects of cold at night G.
It was down 7 million or 16%, primarily due to reduced demand driven by short term cutbacks.
However, we are beginning to see the smaller segment of our business start to recover compared to this year's second quarter transactional revenues increased sequentially almost 7%.
We continued to deliver strong growth and adjusted EBITDA up 40% over last year to $108 billion driven by the increase in sales and the cost efficiency initiatives, we have been and will continue to pursue our adjusted EBITDA margins improved 38% compare.
<unk>, 32% last year, we said we expected the exit 2020 with margins in the upper 30% range and we are delivering on that promise Richard will cover the financial details in a few minutes.
We were very pleased to quickly complete the acquisition of SCPA global too much after announcement I'm. So proud of both teams and while they've accomplished so much in such a short period of time and without everyone. Working remotely. This is a very big of that for clarity and C. P. A global as well.
All those are customers and the entire IP industry together, we're now positioned to offer true end to end solution covering the entire intellectual property science and innovation lifecycle. We have a unique set of solutions that helps accelerate the pace of innovation and position us as the clear.
The global market leader in this large and growing IP market.
Bringing our two companies together is a big win for our customers. When they now have access to a more comprehensive suite of IP related products and services and that's just the beginning we're already working on several combined offerings that we will be released as soon as possible, we swiftly kicked off integration.
Activities that bring our people and products together and we'll deliver the $75 million and cost synergies, which was our come up when we announced the acquisition that then but of July we are moving quickly to harness the excitement and momentum that's been building across both companies and to unlock unique opportunities.
As for our customers and our company moving forward.
[noise] survey, that's growing rapidly thanks to the many new colleagues, who have joined US within the last 12 months from Darts I P customer first now DRG and now SCPA coble with each acquisition, we benefit from their experience and talent and we now have the opportunity to learn and expand our businesses and a rising.
Together.
In addition to the CPGA Global acquisition, we continued to deliver new product offerings and enhancements across the IP and science portfolio.
Earlier this week, we acquired control of Beijing ankle Pat Technology Company Limited a patent information services provider in China founded in 2011 and called path is a highly complementary <unk> investment and and company to our property.
Property portfolio.
Eco Pat has a strong Chinese.
Language capabilities, such as Chinese search for Chinese patterns, and Chinese search for English content and machine translation to Chinese English and Japanese patent content.
Being ankle Pat within our portfolio will allow us to penetrate the fast growing Chinese local IP market. Their primary customers include law firms universities government departments are corporation.
Our industry, leading patent products continue to expand their coverage universe, which is tripled full text <unk> patent coverage in the last 12 months.
During the third quarter, we released an additional 10, new patent authority countries and now offer 75.
Ortiz, making global patent data one of the most geographically comprehensive patent literature databases available our trademark customers now have access to the recently expanded industrial design coverage, which added 16, new registers. The collection now includes 43 registers covering approximately.
At least 15 million records and 56 million images within the Science group. We're now collaborating with open access monitor Germany to provide Weber science data across Germany, Switzerland, and Austria, Austria, we're providing customized web of science publication Grant.
In funding data to increase the impact of scientific scholarship and to enable more equitable participation in research the.
Collaboration strengthens our continued commitment to support open research by investing in community driven projects and enhanced open access data for our products during the third quarter, we launched the Corona virus virology and infectious disease data lake to accelerate research and risk.
Spine to future Pandemics. This is the first of several disease oriented data lakes from clarity, bringing together the comprehensive information and insights that power the company's market, leading tools analytics and services. This includes real world data from DRG is our W. D.
Roddick scientific clinical regulatory and commercial data from our life science business.
Ken cited scholarly references indexed and web assigns and both content and data from award winning New service bio world into one central light source.
We also launched our generics intellect intelligence product to it to enable generic pharmaceutical companies and apiay manufacturers to make timely and more informed data driven decisions as they seek to drive business growth identify new markets products and partners [laughter] now.
For an update on our coal bed responses most of our colleagues continue to work from home. We recently made the decision to keep all offices in the Americas, Europe, and India close through at least the end of this year. Our code that response task force is working through our return to office planning through.
Throughout this pandemic I continue to be very very thankful that how well our team has adapted and overcome any challenges. This is clearly evident and improve colleague engagement and customer delight scores from the surveys. We ran this spring and this fall we just completed our final surveys for 2020.
And I very much look forward to sharing our progress with you at our upcoming Investor day.
Well this pandemic has been personal burden for many weve used it as an opportunity to forge a very important new path forward, we're now accelerating our path.
Into a new way of working and changing how and where we work together and creating an environment and culture that we can be very proud.
A clarity we launched our together and the part strategy and CP a global launch their digital first SCPA programs. Both programs that have made good progress since they were launched we have now fuse. These two programs together. So we can accelerate our progress towards building, a new and better ways of working.
With one program will move faster and build on our collective learnings.
More than 8500 global colleagues are and will benefit I'm very excited that now Fitzpatrick, who joined us from CP, a global where she served as chief people and brand officer is leading us in this critical work. Please tune in again into our Investor Day is now we'll be providing more details about.
Our digital workplace initiative.
This morning, we updated our full year 2020 guidance to include the fourth quarter results for CP, a well be providing our full year 2021 outlook at our Investor Day in November 10 art.
Our 2020 outlets now, including C.P.A. is adjusted revenue of $1.28 billion to $1.295 billion adjusted EBITDA of 480 million to $495 million and adjusted EPS of 55 cents to 61 cents.
For adjusted free cash flow, we now forecast 240 million to $260 million I'll now turn the call over to Richard.
Thank you Gerry it was another very solid quarter, a price we continued to deliver improved KOL key results in 2020 on a year over yet on sequential basis across many key financial metrics, including adjusted revenues adjusted EBITDA and adjusted EBITDA margin.
We reported adjusted revenues of $286 million, an increase of $43 million or 16% at constant currency compared to last years third quarter.
The acquisitions of DRG, adults, IP, which together added to.
32% of revenue growth. This quarter was only partially offset by the <unk> launch up brand protection divested products, which reduced revenue by 6% compared to the prior year period.
Excluding the divested product lines total revenue increased 22% at constant currency in the third quarter.
The foreign exchange impact on our revenues in the third quarter. It was favorable at nearly 2% due to dollar weakness as compared to last years third quarter.
Organic business revenue, excluding acquisitions divestitures and foreign exchange was up slightly versus the prior year period as higher subscription revenue was offset by lower transactional revenue.
On a reported basis total subscription revenue was $222 million, an increase of 9% at constant currency.
Acquisitions over the last 12 months I, just 12% of subscription revenue growth, which was partially offset by the divested product lines, which decreased revenues by 7%.
Excluding the divested businesses subscription revenue increased 16% at constant currency.
Organic subscription revenue increased by $7 million or almost 4% driven by higher sales and price increases for the weapons Science life Science products Tech Street, and comp you Mark compared to last years third quarter.
Subscription revenue renewal rates were 91% for the first nine months of 2020, and we continued to enjoy strong renewal rates.
We remain very focused on achieving world class renewal rates in the mid 90% range subscription subscription revenues accounted for 78% of adjusted revenues in the quarter income.
Including C.J. Global from Q4 onwards will result in recurring and recurring revenues to approximate 83% of total revenues on a pro forma basis.
Transactional revenue increased to $64 million up $22 million for 52% year over year on a constant currency basis, driven by our acquisitions.
Acquisitions added 68% of transactional revenue growth on the product line disposals, lower transactional revenues by less than 1%.
Organic transactional business revenues decreased by $7 million or 16% due to low with assigns backfile sales and lower comp you Mark such and Tech Street revenue.
The Tech Street transactional decrease was due to prior year comparative Ben is benefiting from a large bi annual standards release at the start of Q3 2019.
That is a bi annual release did not enjoy the lift in Q3 2020.
Hey, CV growth was 9% for the third quarter, which includes acquisitions.
Excluding divestitures ACB growth was up 15%.
And on and on ongoing basis.
<unk> increased by 4% and was primarily driven by organic growth and annual price increases.
Turning now to performance across our two product groups for the science group revenue increased by $53 million or 38% to $191 million at constant currency driven by the acquisition of DRG.
Organic business revenue increased by 2% led by higher subscription and services revenue within the life Sciences product family, partially offset by lower transactional revenue.
But the intellectual property group revenue for the third quarter, excluding the divestitures increased 1% to $96 million or constant currency driven by the thoughts IP acquisition okay.
Organic business revenue for the IP group decreased by less than 2% I subscription revenue growth was offset by lower comp you Mark and texture, each step Tech street such volumes.
On a reported basis IP group revenue declined 11% due primarily to the divested products.
Adjusted EBITDA in the third quarter increased by $31 million for 40% to $108 million compared to the prior year period.
This was driven by the increase in revenue and strong margin flow through contributions from acquisitions portfolio rationalization and the benefits of the cost saving initiatives.
Our adjusted EBITDA margin continues to move closer to the 40% range margin improved by 610 basis points to 37.8% as compared to 31.7% in last years third quarter.
Cash taxes in the third quarter were $12 million compared to $7 million in the prior year period. The primary driver of the increase was using U.S. income tax payments that were deferred until July the 15th of this year due to the kind of its pandemic.
Adjusted net income increased by 23% to $59 million for the third quarter and adjusted diluted EPS was 14 cents.
The weighted average share count used to calculate adjusted EPS increased by 24% or 79 million shares since last year is that of course, a different by the issuance of ordinary shares in conjunction with the exercise of the definition of DRG.
And the exercise of public warrants earlier this year.
It's also worth noting that the share counts in this year's third quarter increased by 13 million shares on a sequential basis compared to this years second quarter.
This increase is the results of the shares issued in the June 2020 primary offering being fully reflected in the current quarter calculation versus a weighted average number of shares used in the Q2 calculation.
Capital expenditures increased by $35 million on a cash basis compared to last years third quarter.
Taking capital expenditure accruals into account Capex Capex was up $26 million year to date September compared to prior year.
With our remote working environment, we are seeing high levels.
Application development across all the portfolio.
A higher content contracts as well as some timing impacts from accelerated spend on laptops due to the digital first initiative arising from the credit pandemic.
We ended the third quarter with $601 million in cash in connection with the closing of the CKD clinical acquisition October the first we used $538 million of cash on hand, and we incurred an incremental 1.6 billion or borrowings under our term loan facility to fund the repayments of seat.
Like we'll stat.
Additionally, we issued approximately 217 million ordinary shares to full not CPH label shareholders.
Our total gross debt at the end of September.
Into September Twentytwenty was $1.95 billion.
With the incremental borrowing a say say took the CPGA acquisition. Our total debt now stands at 3.55 billion on a gross basis with net debt at approximately $3.4 billion.
Standalone adjusted EBITDA, which we are required to report on a trailing 12 month basis pursuant to the reporting covenants contained in our credit agreement an adventure was $458 million. Please refer to our earnings release form 10-Q for reconciliation from net loss to adjusted EBITDA I'm from.
Adjusted EBITDA to stand on adjusted EBITDA, we.
We ended the third quarter the price of the incremental borrowings with a net leverage ratio of 2.9 times.
Our current leverage ratio on a pro forma basis, including Cpk global as adjusted EBITDA and the recent borrowings is approximately 4.3 times. Our goal is to be in the low threes low three times range in the medium term with that I'll now turn the call back to Jerry.
Thanks, Richard Great job before we open the line for questions I want to thank once again, our more than 8500 colleagues around the world for their amazing dedication and hard work. This year. They continue to truly impressed me with their incredible accomplishments. Despite the challenges of the pandemic.
That has been introduced to the way we all work our virtual Investor Day as mentioned earlier is scheduled for Tuesday November 10, we really hope you can join us as we will be providing an in depth look at our business, our strategies 2021 financial outlook and future goals, we're now ready.
To take your questions as a reminder, please limit yourself to one question then return to the queue operator please.
Thank you we will now begin the question and answer session.
Ask a question you May press Star then one on your Touchtone phone. If you are using a speakerphone. Please pick up your handset it's more pressing the keys to withdraw your question. Please press Star then too.
The first question today comes from Shlomo Rosenbaum Stifel. Please go ahead.
Hi, Good morning, Thank you for taking my questions and Jerry I, just want to get into a little bit of how you're tracking on your organic growth versus your expectations in the in the core business. If you were to exclude all the acquisitions and the currency and everything did the company grow revenue on a year over year basis.
And how are you tracking and I guess as a follow on would be is the increase from SCPA global is increase in guidance completely from SCPA global or CPT global offsetting any potential weakness in the core business just trying to gauge how things are going right now.
Yeah, No great question, Shlomo two or three things, let's just step back when.
When we closed on DRG and.
On February 28, this year, we gave new guidance, which we then adjusted.
From the standpoint of the original guidance, we reduced by 30 million midpoint $30 million that was we felt mostly.
Transaction. We also said we thought we'd see Q3, the beginning a stabilization that Q4 start to increase year over year on transactions, So where we're at today is two or three things.
One thing that's really important in hindsight.
I wish I had that done differently, we've always given I've given annual guidance for many years as you know we don't give quarterly we did say that with the acquisition of DRG that 60% of their revenue came in the second half which results in the hockey stick. We also said that we.
We're working on that chart and others to reduce that hockey stick in the future. The thing we probably should have made clear in hindsight is that 60% of that second half, 60% a DRG comes in the fourth quarter. So you just set that all aside what you'll see is that worse.
Bought on of where we expected to be on a global basis with.
The organic growth for our renewal business and our annual subscription base couldn't feel better about that expect that to wrap up a good year were below our expectations.
On the on the transaction however, as I mentioned in my call. We were sequentially up in Q3 over Q4 and will will be hopeful that that plays out for Q4. So.
Very good about where we're at with your organic growth on the annual subscription base that will continue to play out and feel very good about what's starting to change from a transaction standpoint.
The new guidance. We gave you obviously includes one quarter of C.P.A.C.P.A.'s done a good job too.
And.
As you'll hear a lot.
Or November 10th conference.
What what we're expecting to see in 2021.
And that I'm going to give you my views that two things Richard and I will tell you what our goals are to exit 2022.
My views of where we'll be in 2023. So we look forward to doing that Richard anything else on that.
No I think Thats still think thats covered it.
Thanks Omar next question.
The next question comes from Manav Patnaik of Barclays. Please go ahead.
Thank you.
Okay, maybe just a follow up on that could you remind us of.
The moving pieces in that transactional bucket like what they what all is in there and why.
Yes, it does.
Expectation.
I guess, it's probably early for you to see it but can it sounds like you know the fourth quarter Lockdown the coming so do you think that that Q over Q sequential improvement you know might not show up in the fourth quarter.
Let's work backwards great question. Thanks, I'll take the second part Richard you take the first part and breakout for them. The three pieces, we look at what transaction business.
No I think we're feeling fine about fourth quarter.
And as the Lockdowns continue we're.
We're seeing as I said the pickup.
Pieces of the transaction business and part of that is a significant pickup in Q4, as I said with DRG and their repetitive business and their transaction business, but Richard give them the play out of about the 17% that is.
Not subscription base.
Yes, so there were essentially born.
Good morning, there are essentially three components. The first component in transaction lot Backfiles and customer data custom beta sales like for this quarter compared to prior year.
Then we have to compete knock such business.
[music].
Improved performance as we progress through the quarter. So we're starting to see some definitely some improvements from not seen earlier in the year when the when the pandemic really impacted that complements such component and then the third piece would be Tech Street and as I mentioned in my in my scripts to Tech Street had a lot a significant.
Couldn't buy annual stands released last year in the third quarter, which lifted prior year comps and we almost didn't enjoy that this year and then the final piece is on the professional services side, that's holding up well, particularly in the life Sciences vertical which on which is one with which is one with what you would expect.
Thanks, Richard I, just add a bit to that because it's so important.
Historically, where they did not invest in the services business professional services.
And we look forward to the progress book Tar and Jeff both have done a great job in moving that forward and it's really not one off bids what it is is pulling through our annual subscription base, which gives us a unique situation. So feel very good about that part as we move forward.
Thank you Ben next question please.
The next question comes from Toni Kaplan of Morgan Stanley.
Thank you so much I was hoping you could give some additional color on a pack and just looking at the 10-Q organic growth. There was basically flat in the third quarter, but that solid second quarter organic growth of 6.7%. So it seems like it's driven by transactional.
But can you just talk about what got worse in Threeq you versus to Q in a pack and how you're thinking about the recovery there and also maybe just with Enco. Pat you know does this help accelerate your timeline for capturing the growth that you're seeing in China, and you know anything to add on that.
Growth in that no great question, Great question, Tony I'll work backwards and Richard will pick up the first part of your question.
What is the white flat Richard in Q3, and Asia Pacific versus the second half, 7%. We saw in the first half and what we expect as you will see for the whole year and Copac has a great addition for us and that gives us a unique situation of being.
Able to sell their product around the world.
And also to sell even more of our products.
In into China. So it's a good one are very pleased with it won't see a big pickup in Q4, we'll see that as the year evolves in the 2020 and 2021.
Jeff and David Lu our head of Asia Pacific did a great job and getting that one put in place Richard let's be let's help that because tonys question's a good one of the Q3 and Asia Pacific.
Yes, yes, you're right I mean year to date gross so Asia for the Hawk said, but it was flat in Q3 with growth in Q1 and Q2, what we saw in Q3 is backfile sales in the quarter for Asia Pac was lighter than prior year and that's the primary driver.
Hi, good morning.
Good morning.
And auctions, however, we do want to be always preferred acquirer.
As we have been in each of these cases, so feel very good about that I'll just open up.
Mark for Jeff in just a second with one common that we feel very good in both our science business.
And in our IP business with having all the critical assets that are needed and what we look forward to with acquisitions is complementing them. Both geographically like we just did with China more of those to come and then also in adjacent markets Jeff.
Yes, Thanks, Jason Great question, I mean, we're always looking to grow our portfolio. So we always see opportunities out there in the market I think you kind of hit it on the head Andrew than that when we look at this EPA acquisition.
It definitely improved our product mix and we think that that helps us create better packages to solve customer problems. So we're very excited about that as a big part of our strategy is cross selling up selling as we move forward, but the other thing that we're really focused on is really how do we how do we make investments in our portfolio to leverage our data assets and as Jerry said before we are definitely focused in our area.
Analytics capabilities and the advisory services that we have as we think that that's a nice add on and SCPA creates a nice channel for that as well. So all in we're always looking at opportunities and as Jay said Theres plenty of opportunities in the market for us and we're going to continue to evaluate them.
And we feel very good about the teams we have in place on integration, we're getting better everyday with that.
And.
We are ready for more if and when they become available. So thank you for the question next question. Please.
The next question is from Seth Weber of RBC capital markets.
On the progressive so.
To that degree, it's certainly cancellations that have an impact on the calculation and cancellations were slightly higher at year to date September compared to prior year. However, you business was stronger year to date compared to prior year New business doesn't go just doesn't go into the equation north the pricing.
Increases so it is the cancellations being slightly higher year to date September compared to P.Y., but.
But I think what's really important to measure is the ACB growth because that is the more holistic complete view of what's actually happening to the underlying revenue base of the company in terms of that recurring annual revenue stream and that was up 4% yet.
4% at the end of the quarter compared to P.Y.
The organic for the base business. So that's a that's in line with our expectations.
So I think that's the that's the key the key the key a key.
Key factor there.
It's Richard I, just add one thing to that because it's so important you're going to get good details on our November 10th.
Investor Day about what we've done with the global business centers. We're ahead of schedule there and the other thing we're learning, including with the addition of CP, a our opportunity to handle more customers insights than ever before is huge and.
We'll continue to do that feeling really good about that progress will turn and I were talking about just before the call. We've got a lot of things that we'll be able to do to focus our outside sales folks better than ever before as teams on global markets. So we're going to win on.
Both sides and I feel best I felt about our ability to see the kind of organic growth. We talked about we said we expected to exit.
2021 at 6% to 8% organic growth.
And you will see guidance as I said on November 10 minutes, but feeling very good about that despite the pandemic. Thanks Seth next question.
As a reminder, if you do have a question you can press Star then one the next question comes from George Tong of Goldman Sachs.
Hi, Thanks, Good morning, I was.
Wanted to dive deeper into organic revenue growth performance subscription revenue was up 3.5% organically in Threeq. You. This compares with 3.6% organic subscription growth in Twoq. You can you elaborate on the puts and takes that caused subscription organic revenue growth to moderate and some specific.
Initiatives that will help reaccelerate subscription organic revenue growth next quarter.
Yes go ahead, Richard Thanks, George just a reminder.
Just a reminder, all the things we've laid out that will get us out organic growth are in place today and being executed well cover those in great detail on November 10th and I feel very good about it but great question George Please.
Police Richard.
Yes, sure. So in terms of subscription revenue growth absolutely slightly higher tick in Q2 compared to Q3. Now Q2 did include the benefit to us closing out some annual contracts that we mentioned on the call that had had Q1 renewal date renewal dates that did slip into Q2 because that was.
That was sort of when we're in the eye of the storm at the end of March with the with the with the pandemic really impacting all companies. So we did have some slippage of renewals from Q1 into Q2, and we pick those up in Q2, So we had a bit of revenue lift by recognizing revenue.
For the six month period for example in some contracts in that second quarter period, and that sort of that that impact has normalized as we traveled into Q3. So Q3, Nevertheless, still very solid performance three and half cent we.
Which obviously includes price increases I would say that this you're tying this this question also back to the previous question from Seth around renewal rates. We are pivoting. The sales organization currently where we're moving a significant corpus of accounts from the field organization into our Threeq.
Business centers into inside sales in Chandler, Arizona.
London in EMEA, London for EMEA and of course, Penang, Malaysia for Asia Pacific The expectation is that that will.
Increase the velocity of new business, because we'll have a broader interface with the market and we'll also have more regular touch points with the long tail of players that long tail in the account base in that role hypothesis is that absent improved retention rates as well simply because we'll have more frequent interactions with our clients so that.
That pivot will drive organic subscription growth and it also complements our renewal rates as well.
Thanks, Richard Thanks, George next question please.
Your next question comes from peak Synthon of Citi.
Good morning, Thanks for the question Kerry.
Kerry Thanks for the added clarity on the DRG second half cadence.
But I was hoping you could talk to.
What's the typical seasonality that you see in the CPG business and perhaps also how do you think about clarify rates overall exposure to potential budget flush activity.
Year end.
And thoughts ahead, given the current environment that would be helpful. Thank you yeah.
Yeah No great question. Thanks, a couple of things.
As CPGA is spot on with the excluding DRG, what's the split that.
Flare rates had which is 49 first half 51 second half. If you remember this has been an amazing year. We said we thought a first half second half split would be 48, 52, rather than 49 51, excluding DRG and I'd.
I think we we feel very good about that we're off and running that couldn't be prouder of our CPGA team and where we're at with that so you'll see I think the best way to explain that and then I'm going to ask Luke to our to just comment on DRG and what we are doing and how he's feeling about.
Further out versus our expectations, but I think what you'll also see as we move forward.
Into 2021 is a balance that's probably 48, 52 or thereabouts, including DRG, but because of some of the things we're doing but we'll give you that real clear update in November 10th booked our fleets.
Yeah. Thank you Gerry just just a few comments on D.R.J. I mean, when we fully integrated technology into our business. Yeah. That's really allowed us to really start operating as a combined in cohesive business are we starting to see the fruits of that certainly in the.
They all turned in.
Some of the pipeline and deals and so forth that we're creating a we're starting to just realized some of that pickup.
So we feel very good.
Going into Q4.
And responding and managing and leveraging our growth targets there.
Thanks book to our next question please.
The next question comes from Zach Cummins of B. Riley FBR.
Yeah, Hi, good morning, Thanks for taking my question.
Some more clarity on the three global business centers I mean, do you have a timeline we expect all three of these to be fully operational they.
They are now.
Alright, Okay got it I thought there was still like a hiring ramp for some of them wherever they need to be filled out nerdy question, Zach and let me just add to that I welcomed on Monday. The last 21 that we will be hiring and per name, which puts us well over.
Well over our original goal because whats already happened a lot of our support organizations are moving skills into that area and if you think about where we'll be at as we go into 2021.
All three of those are fully staffed by the way.
In addition that we'll talk about again on November 10th is where we'll end up with our global center for the EMEA region.
Region going forward, which is a big pick up in a big plus for us for C.P.A., So feeling really good about that but.
I would make two comments I've had the opportunity to see not me personally, but see all that new hires and all of the global centers and we're getting great talent to I would say were probably.
The one one of the good things with the pandemic is.
We've got really great talent as we go forward so feeling very good about the job Mike Mccarthy has done with the David Jeff.
And move Char and were really well set up for that so what you will see us going forward is more and more best cost centers offshoring, if you will.
I think.
Think about.
The ability to 24 by seven which is the other thing we have a range so in.
In other words with the three business centers will be live 24 by seven for customers everywhere in the world. So feeling very good about it. Thank sack next question.
There are no further questions. This does conclude our question and answer session I would like to turn the conference back over to Jerry's team for any closing remarks.
Thank you very much and we look forward to continuing to deliver what I feel is really great progress and this pandemic and in fact, continuing better than ever before.
Last comment I'll make is we really hope you all spend the time on November 10, I'm eager to do Oh. The program. We've got a lot to cover and we'll make sure that we've got plenty of time for questions. There too. So thank you all very much as I said I'm incredibly.
Really proud of our team at what Weve accomplished wonderful additions.
What's the from the M&A standpoint, and and I would just say, we'll close the fact, we're just getting warmed up thanks everybody.
The conference has concluded. Thank you for attending today's presentation you may now disconnect.